VRDN icon

Viridian Therapeutics
VRDN

Overview Fund Activity

6 hedge funds and large institutions have $1.12M invested in Viridian Therapeutics in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

Holders
6
Holders Change
+5
Holders Change %
+500%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HA
1
Heartland Advisors
Wisconsin
$810K
2
PCM
2
Perkins Capital Management
Minnesota
$285K
3
TRCT
3
Tower Research Capital (TRC)
New York
$9K
4
GSC
4
Ground Swell Capital
South Carolina
$7K
5
U
5
UBS
Switzerland
$6K

Top Sellers

1
EEG
1
E.E. Geduld
$0
Name Market Value Shares Shares
Change 		Shares
Change %
HA
1
Heartland Advisors
Wisconsin
$810K 180,000 +180,000 New
PCM
2
Perkins Capital Management
Minnesota
$285K 63,300 +63,300 New
TRCT
3
Tower Research Capital (TRC)
New York
$9K 2,032 +2,032 New
GSC
4
Ground Swell Capital
South Carolina
$7K 1,653 +1,653 New
U
5
UBS
Switzerland
$6K 1,285 +1,285 New
EEG
6
E.E. Geduld
– – -10,000 Closed
Morgan Stanley
7
Morgan Stanley
New York
$0 6 +6 New